Kobayashi Erica Sanford, Lotan Nava Shaul, Schejter Yael Dinur, Makowski Christine, Kraus Verena, Ramchandar Nanda, Meiner Vardiella, Thiffault Isabelle, Farrow Emily, Cakici Julie, Kingsmore Stephen, Wagner Matias, Rieber Nikolaus, Bainbridge Matthew
Rady Children's Institute for Genomic Medicine, San Diego, CA; Division of Critical Care, Department of Pediatrics, Children's Hospital Orange County, Orange, CA.
Department of Genetics, Hadassah Medical Center, Jerusalem, Israel.
J Pediatr. 2024 Nov;274:114180. doi: 10.1016/j.jpeds.2024.114180. Epub 2024 Jul 5.
To evaluate a novel candidate disease gene, we engaged international collaborators and identified rare, biallelic, specifically homozygous, loss of function variants in SENP7 in 4 children from 3 unrelated families presenting with neurodevelopmental abnormalities, dysmorphism, and immunodeficiency. Their clinical presentations were characterized by hypogammaglobulinemia, intermittent neutropenia, and ultimately death in infancy for all 4 patients. SENP7 is a sentrin-specific protease involved in posttranslational modification of proteins essential for cell regulation, via a process referred to as deSUMOylation. We propose that deficiency of deSUMOylation may represent a novel mechanism of primary immunodeficiency.
为了评估一个新的候选疾病基因,我们与国际合作者合作,在来自3个无关家庭的4名患有神经发育异常、畸形和免疫缺陷的儿童中,发现了SENP7基因罕见的双等位基因、特别是纯合子功能丧失变异。他们的临床表现特征为低丙种球蛋白血症、间歇性中性粒细胞减少,所有4例患者最终均在婴儿期死亡。SENP7是一种类泛素特异性蛋白酶,通过一种称为去SUMO化的过程,参与对细胞调节所必需的蛋白质进行翻译后修饰。我们提出,去SUMO化缺陷可能代表了原发性免疫缺陷的一种新机制。